- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Health Care Facilities & Svcs
- Sub-Industry: Health Care Services
NeoGenomics Inc+ Add to Watchlist
NEO:US4.3600 USD 0.0500 1.16%
As of 20:10:00 ET on 11/26/2014.
Company Profile for NeoGenomics Inc (NEO)
NeoGenomics, Inc. operates a network of clinical laboratories that specialize in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.
Key Executives for NeoGenomics Inc (NEO)
|Douglas M VanoortChairman/CEO||George A CardozaChief Financial Officer|
|Robert J Shovlin "Rob"Chief Operating Officer||Steven A RossChief Information Officer|
|Maher AlbitarChief Medical Officer||Steven C JonesExec VP:Finance|
|Robert H HorelVP:Sales & Marketing||Edwin F Weidig IIIDir:Finance/Principal Acctg Ofcr|